Records containing: Neuroendocrine Tumor of Pancreas
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-09-09PRIME Study: Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients
-
CLINICAL_TRIALS study record update · 2025-11-04A Phase 1, First-in-human Clinical Trial of [212Pb] VMT-alpha-NET Using a Forward Dosimetric Planning Technique to Treat Refractory or Relapsed Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2025-10-01Lurbinectedin as a Second-line Treatment for High-grade Pancreatic Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2024-12-18PRIME Study: Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients
-
CLINICAL_TRIALS study record update · 2024-07-26Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-06-25Randomized Phase II Trial of Everolimus 5 mg vs 10 mg/Daily for Patients With Advanced Neuroendocrine Tumors
-
CLINICAL_TRIALS study record update · 2023-09-2268Ga-DOTATOC Radio-Guided Surgery With β-Probe in GEP-NET
-
CLINICAL_TRIALS study record update · 2021-07-27Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma